Evidence-based guidance for national infection prevention and control (IPC) programmes is needed to support national and global capacity building to reduce healthcare-associated infection and antimicrobial resistance. This systematic review evaluated the evidence on the effectiveness of IPC interventions implemented at national or sub-national level to inform the development of World Health Organization's guidelines on the core components of national IPC programmes. CENTRAL, CINAHL, EMBASE, MEDLINE, and WHO IRIS were searched from January 1, 2000 to April 19, 2017. Twenty-nine studies meeting the eligibility criteria were categorised according to intervention type: multimodal; care bundles; policies; and surveillance, monitoring, and feedback. There was evidence of effectiveness in all categories but the best quality evidence was on multimodal interventions and surveillance, monitoring, and feedback. We call for improvements in study design, reporting of research and robust evidence, in particular from low income countries, to strengthen the uptake and international relevance of IPC interventions.  There is some evidence of effectiveness for two other interventions, namely, care bundles and policies.
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Introduction
Healthcare-associated infection (HAI) is a major global health problem. It affects millions of patients worldwide every year. 1,2 HAI has serious implications for patients and health care systems. 1 A large burden of HAI exists worldwide, despite a call to action over the last decade to make care safer. 3 Estimates suggest 80,000 patients/per day have at least one HAI on any given day in Europe, corresponding to a prevalence of 5·7% of hospitalized patients (95% confidence interval (CI): 4·5% to 7·4%) suffering from HAI. 4 The estimated HAI prevalence in low-income countries ranges from 5·7% to 19·1%. 1 The contribution of antimicrobial resistance (AMR) to HAI at a global level is not well described. However, it is known that wide national variations in multidrug resistance exist, with low resistance rates in some countries, particularly in Northern Europe, and alarming prevalence in others. Extended-Spectrum β-Lactamase-producing Escherichia coli and Klebsiella spp range in terms of the proportion of isolates which are resistant, from 11·8% to 58·5% and from 35·1% to 57·3%, respectively, and for Meticillin-Resistant Staphylococcus aureus (MRSA) from 27·7% to 44·4%. 5 Since AMR moves freely across national borders, coordinated global action is needed to maximise prevention of HAI and containment of AMR.
Infection Prevention and Control (IPC) is recognised as a key strategy in this regard, 6 with the focus being on what are the core components that should be part of any IPC programme, resulting in repeated international calls for evidence-based guidelines for core national interventions. 1, 7 A recent systematic review of IPC programmes, organisation, management, and structure identified ten core components to reduce HAI at a hospital level, 8 but no review exists on the components required for effective national IPC interventions. Previous World Health
Organization (WHO) guidance on national IPC core components 9 was based only on expert opinion. New evidence-based guidelines, including recommendations for core components of effective IPC programmes at the national and healthcare facility level have been developed by a panel of international experts to support the global prevention of HAI and reduce the burden of AMR. These guidelines were based on the available evidence and its quality, the balance between benefits and harms, cost and resource implications, acceptability and feasibility, and user and patient values and preferences. [10] [11] Where studies not meeting our inclusion criteria were not available, the panel of international experts deemed it crucial to make best practice statements on key core components to be recommended at the national level. In this systematic review, as part of the guideline development, we aimed to evaluate the evidence on the effectiveness of IPC interventions at the national level.
Methods
This systematic review was conducted according to a protocol (appendix, page 3) and is reported according to the PRISMA guidelines.
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Search strategy and study selection 
Disagreement between reviewers was resolved by discussion or by a third reviewer (JR).

Data analysis
Data were extracted: (appendix, page 23) by two independent reviewers for 30% of the studies. The remaining studies were data extracted by one reviewer and checked by a second reviewer (LP, EC, KC, PF, TH, JM, LM, VN, JR). Disagreement between reviewers was resolved by discussion or by a third reviewer (LP, JM).
Quality assessment: Risk of bias of individual CRT, NRT, CBA studies, and ITS studies were assessed using standard EPOC risk of bias criteria, 16 resulting in a summary assessment of overall high, low or unclear risk of bias. 17 Risk of bias assessments were conducted by two independent reviewers for 20% of the studies and by one reviewer, checked by a second reviewer, for the remainder of the studies (LP, JM, TH, PF, KC, EC, VN, JR). Disagreement between reviewers was resolved by discussion or by a third reviewer (LP, JM). The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) system [18] [19] [20] was used
to grade the quality of the body of evidence, where one existed (LP, JM). Two independent reviewers (SM, AM, JR) used the Phillips' checklist 21 to critically appraise the methodological quality of each economic study. 22 Disagreement between reviewers was resolved by discussion or by a third reviewer (LP). A narrative summary was produced in line with
Cochrane recommendations (LP, JM, SM). 23 Studies were considered for meta-analysis; however, due to heterogeneity in interventions and primary outcomes, no meta-analysis was conducted as it was considered statistically inappropriate. Therefore, results were synthesised in a narrative form according to the type of IPC intervention being evaluated.
Results
The database searches identified 9,960 studies. A further 139 studies were identified by manually searching the reference lists of included studies, resulting in 9,777 studies after removing duplicates, all of which were screened against the eligibility criteria. The majority of these (9,422) were excluded at the title/abstract screening stage, with a further 326 excluded at full-text review. Twenty-nine studies meeting the inclusion criteria were included in the systematic review (figure 1, table 1).
Studies were from the USA (18), [26] [27] [28] [29] 32, [36] [37] [38] [40] [41] [42] [43] [44] [45] [46] [47] 49, 50, 53 England (3), 24, 34, 51 Australia (2), 35, 39 Hong Kong (2), 25, 30 Brazil (1), 31 Israel (1), 48 England and Wales (1), 52 and Germany (1). [42] [43] [44] [45] ; IPC policies (n = 6 studies, 2,444 hospitals) [46] [47] [48] [49] [50] [51] ; and IPC surveillance, monitoring and feedback (n = 2 studies, 16 area health services and eight hospitals). [52] [53] Multimodal interventions aim to improve an outcome and change behaviour through implementation of several elements, most commonly system change, staff education, monitoring and feedback, reminders, and culture change. 54 Implementation uses an integrated and multidisciplinary approach and can be supported by practical tools, including care bundles and checklists. Care bundles comprise a small, straightforward set of evidence-based patient focused practices (generally three to five) that improve patient outcomes when performed collectively and reliably. 54 Care bundles were differentiated from multimodal interventions as they are an implementation tool to guide the delivery of a specific aspect of a patient's care, whereas multimodal interventions generally operate at the level of the organisation to change healthcare workers behaviour through implementation of the abovementioned elements and may include the use of care bundles. 54 This categorisation is used to structure the results and discussion.
Of the 18 studies investigating multimodal IPC strategies, there was one NRT, 24 seven CRT, [25] [26] [27] [28] [29] [30] [31] three ITS studies, [32] [33] [34] three economic evaluations, [35] [36] [37] and four CBA studies. [38] [39] [40] [41] Most of the studies were conducted in acute hospital settings, but four were in LTCFs (table   1) . 25, 26, 28, 30 The multimodal interventions in this review varied in terms of number (ranging from two to eight) and type of components included (appendix, page 24), but were reported by authors as a collective whole with no attempts to distinguish the relative effect of the different elements. The most frequently cited elements were the implementation of a care bundle showed a significant effect on at least one outcome measure. The economic evaluations of multimodal interventions demonstrated cost savings or cost effectiveness (table 2) . [35] [36] [37] Only four studies within the multimodal IPC interventions category measured the same outcome; CLABSI incidence rates per 1,000 patient or central line-days (CL-days). Three studies, all with an ITS design and conducted in a hospital setting, investigated the effectiveness of patient-focused care bundles (table 1) . [42] [43] [44] [45] The patient population for two of these studies were children, with one study 43 48 Neither study that evaluated non-payment for preventable infection 46, 47 showed a significant reduction in HAI, but the use of antiseptics was associated with hospital costs avoided 50 and MRSA screening for high risk specialities was shown to be cost effective in terms of QALY. 51 The task force 48 Quality assessment of the 29 studies (appendix, pages 26 and 27) showed that five CRT were at low risk of bias, 27, 28, 31 one with regard to its primary outcome 52 and another with regard to its secondary outcome. 25 Three other CRT 29, 53 had an unclear risk of bias, one concerning its secondary outcome. 52 One ITS was also at unclear risk of bias, 33 while 17 studies were at high risk of bias, 24, 26, 30, 32, 34, [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] one in relation to its primary outcome. 25 The remaining five studies were economic evaluations [35] [36] [37] 50, 51 ; a narrative summary of the methodological quality of these is available in the appendix, page 28.
GRADE was applicable to assess the quality of the body of evidence for studies assessing multimodal IPC interventions and IPC care bundles as these were the only types of interventions in which the same outcomes were reported in more than one study.
For multimodal IPC interventions, CLABSI incidence rate per 1,000 patient or line days was reported in four studies. 24, 27, 31, 33 The risk of bias for two studies 27, 31 indicated that there was an overall low risk of bias. For one study the reported confidence intervals suggested relatively precise effect estimates, 27 but the intervention in the second study had no effect on CLABSI. 31 The third study 24 had a high risk of bias and the fourth study 33 had an unclear risk of bias. Thus, the body of evidence of multimodal IPC interventions for CLABSI incidence rates per 1,000 patient or line days may be considered low quality.
In the IPC care bundles group of interventions, two studies 42,43/44 reported CLABSI rates per 1,000 line days. These studies used an ITS design and received a high risk of bias, so this body of evidence may also be considered low quality.
Discussion
This review of the effectiveness of IPC interventions was undertaken to inform the development of international guidance on national IPC programmes. Although a high level of heterogeneity of interventions was observed, it was possible to identify four categories of IPC intervention: multimodal IPC interventions (n = 18 studies) [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] ; IPC care bundles (n = 3 studies) [42] [43] [44] [45] ; IPC policies (n = 6 studies) [46] [47] [48] [49] [50] [51] ; and IPC surveillance, monitoring, and feedback (n = 2 studies).
52,53
Evidence of effectiveness of IPC interventions, based on international, national, state or collaborative guidelines and implemented countrywide, region wide or across countries, regions or collaborations, for guideline development was limited to a small number of individual studies. Of the 29 included studies, high quality evidence with a low risk of bias was provided by four studies of multimodal interventions, 25, 27, 28, 31 and one study of a monitoring, surveillance, and feedback intervention. 52 In addition, a moderate level of evidence was provided by two studies of multimodal interventions 29, 33 and a study of monitoring, surveillance and feedback interventions 53 with an unclear risk of bias. Another study of monitoring, surveillance and feedback interventions 52 had both primary and secondary outcomes. It had a low risk of bias for the primary outcome and a moderate risk of bias for the secondary outcome.
Multimodal interventions were supported by the highest number of studies, with the majority demonstrating effectiveness. However, they evaluated IPC components collectively while the individual impact of each component was not identifiable, nor was which interventions collectively had the best impact on outcome, as no two studies included the same combination of interventions. This is a recurrent theme in the IPC literature, both at an organisational level and wider. 8.9 Surveillance with active feedback tends to report positive effects, even when it is a single intervention. Effective studies used national HH data for feedback at an individual level to drive behaviour change 52 and national infection rates as a benchmarking tool to drive comparisons and improvement across hospitals. 53 Additional studies reporting a positive impact of national surveillance exist outside this review but were not included as they did not meet our inclusion criteria mainly linked to the absence of control comparators. Indeed, following introduction of national surveillance at one point in time in all hospitals, the first year is normally used as a proxy baseline and temporal trends are reported thereafter. [56] [57] [58] [59] [60] Nonetheless there are a number of papers in the IPC literature reporting observational evidence that when national HAI surveillance is introduced there is a significant reduction in HAI seen by year 3 of the programme. This impact has been observed in Germany with SSI and MRSA, 59, 60 France with SSI and MDRB, 56, 57, 61, 62 Italy with SSI, 63 Finland with CDI, 60 and the USA with overall HAI. 64 The review identified some evidence, although subject to bias and low quality, for two other interventions, namely, care bundles and policies, including development of guidelines accompanied by related healthcare workers' education and training. Absence of evidence meeting the inclusion criteria does not of course infer absence of effect, or importance of the other key interventions required for national level IPC programmes. No study was found to evaluate the effectiveness of establishing a comprehensive national IPC programme to reduce HAI and AMR. However, the experts evaluating the evidence strongly affirmed that each country should have a stand-along, active national IPC programme.
The strengths of this review are that it was conducted in a systematic and rigorous manner and that to the authors' knowledge this is the first systematic review evaluating IPC interventions to guide the implementation of effective national IPC programmes. The comprehensive search comprised an extensive range of appropriate index terms and free text words and spanned four major databases and one specialist repository over a wide time period (January 1, 2000 to April 19, 2017) . Citation searches of included studies were also conducted. Other methodological strengths include the focus on studies meeting the EPOC design criteria [13] [14] [15] and the use of design-specific quality assessment tools recommended by
Cochrane and EPOC. [16] [17] [18] [19] [20] [21] [22] [23] However, despite aiming to be inclusive of all countries and having the resources to translate studies in several languages, the focus on studies meeting the EPOC criteria resulted in studies from only seven high-income countries and one uppermiddle income country being included. This emphasises the need to build research capability and capacity specifically to enhance the evidence base from a wider range of countries, and in particular from low-/ middle-income countries.
The review describes a lack of high quality studies using comparable primary outcomes. This limits the development of evidence-based international guidance to shape policy and practice. However, clear recommendations can be made for improvement in future research design for such studies to develop a viable evidence base. Exclusion of many studies was due to their study design. The majority were cohort studies that did not meet the EPOC study design criteria. However, these studies could still provide some important and valuable evidence in the absence of studies with more rigorous study designs and can be taken into account when guidelines are being developed. As a consequence, there is a need for improved research design with CRT, better designed epidemiology studies including rigorous time series analysis, 14 and the consistent use of core outcomes to inform the future evidence base for IPC. A stepped-wedge design would be ideal as it would potentially allow the evaluation of the effect of different interventions introduced in a step-wise manner in different sites. Furthermore, the use of consistent measurements for specific outcomes according to standardised definitions is crucial in order to make meta-analysis feasible and allow the assessment of impact from the body of the evidence of studies with the same outcome. In addition, it is important to measure, both outcomes and processes, in particular if an experimental design is not possible. This is crucial to demonstrate that behavioural and practice changes have occurred and can help relate the changes to the intervention in noncontrolled and non-randomized studies. 65 It is recognised that such experimental approaches are challenging as national policy initiatives for IPC interventions are often implemented at pace, not designed with evaluation built in from the outset, and evaluated retrospectively, if at all. 66, 67 In addition to the lack of studies meeting the EPOC design criteria, there were key omissions relating to the detail of reporting about the intervention content, how it was implemented, and its hypothesised mechanisms of action. These must be addressed in future IPC research as they are crucial for replicability and dissemination. The studies that evaluated the effect of a multimodal IPC intervention, for example, tended to report positive effects from the intervention whereas challenges encountered and related solutions, if any, were neglected.
Furthermore, the relative contribution of individual elements was usually not identifiable, nor was any sense of the impact of particular combinations of elements upon outcome. This is a recurrent theme in the IPC literature which seriously limits our ability to build cumulative and transferable evidence relating to intervention elements. 8, 9 In addition, studies tended not to have specified any theoretical underpinning. The use of theory provides a hypothesized mechanism of change. This can provide a rationale for the delivery of specific elements in particular combinations in specific contexts and can improve the coherence of complex interventions and limit the inclusion of extraneous intervention components.
These key omissions can be remedied by using behavioural theories and tools such as the Theory Coding Scheme 68 and the Behaviour Change Technique Taxonomy, 69 wider approaches from implementation science, and quality improvement methodologies.
Together, these inform intervention development, intervention evaluation and foster reporting of key outcome measures. Culture and social context are also important in order to understand the success or failure of IPC interventions. 70 These should also be taken into account to better understand the implementation of IPC strategies. 71 This is particularly true with regard to the dearth of research in low-income countries. Implementing effective interventions within the developed world alone will not help to contain HAI and AMR in the global context. Finally, studies need to be reported in such a way that they can be replicated in different contexts. There is a growing body of literature to guide authors [72] [73] [74] that could strengthen reporting practice.
In conclusion, the best available evidence to inform international recommendations about effective IPC programmes comes from individual studies on IPC multimodal interventions and studies on surveillance, monitoring, and feedback. We call for urgent improvements in the use of more robust study designs in IPC research and research investigating the cultural and international relevance of IPC interventions. This review has made a major contribution to illustrate the state of current evidence in relation to national and sub-national IPC interventions. The findings provide direction for international guidance which will shape global action to prevent and control HAI and contain AMR. 
